Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$13.01 - $27.22 $80,662 - $168,764
-6,200 Reduced 17.54%
29,157 $408,000
Q1 2022

May 17, 2022

BUY
$20.94 - $27.5 $192,648 - $253,000
9,200 Added 35.17%
35,357 $856,000
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $256,853 - $414,422
-15,298 Reduced 36.9%
26,157 $611,000
Q3 2021

Nov 15, 2021

SELL
$15.78 - $24.77 $144,387 - $226,645
-9,150 Reduced 18.08%
41,455 $689,000
Q2 2021

Aug 17, 2021

BUY
$19.4 - $27.42 $981,736 - $1.39 Million
50,605 New
50,605 $1.23 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.24B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.